Skip to main navigation
Skip to search
Skip to main content
Sort by
Medicine and Dentistry
Tuberculosis
100%
Hansen's disease
97%
African Trypanosomiasis
96%
Infection
66%
Diseases
64%
Prevalence
48%
Rifampicin
48%
Post-Exposure Prophylaxis
47%
Visceral Leishmaniasis
47%
Trypanosoma brucei
37%
Cross Sectional Study
36%
Health Care Cost
33%
Health Care Personnel
32%
Drug Resistant Tuberculosis
31%
Human immunodeficiency virus
31%
Single Drug Dose
24%
Mycobacterium leprae
23%
Enzyme Linked Immunosorbent Assay
23%
Diagnostic Test
22%
Arm
22%
Cluster Randomized Trial
20%
Ethiopia
19%
Vector Control
19%
Multidrug Resistant Tuberculosis
17%
Low and Middle Income Countries
16%
Systematic Review
16%
COVID-19
15%
Antigen
15%
Neglected Tropical Diseases
15%
Drug Administration
14%
Drug Resistance
14%
Real-Time Polymerase Chain Reaction
14%
Public Health
14%
Rapid Diagnostic Test
14%
Tuberculosis Treatment
14%
Health Service
14%
Sputum
14%
Quality of Life
14%
Immunoglobulin M
13%
Mixed Infection
13%
Acoziborole
13%
Severe Acute Respiratory Syndrome Coronavirus 2
13%
Community Participation
13%
Bedaquiline
13%
Prospective Cohort Study
13%
Chikungunya virus
13%
Scoping Review
13%
Pathogen
12%
Skin Biopsy
11%
Health Outcomes
11%
Case Finding
11%
School-Aged Child
11%
Surveillance System
11%
Cohort Effect
10%
Treatment Outcome
10%
Oral
9%
Malaria
9%
Tsetse Fly
9%
Leishmania
9%
Parasitic Disease
9%
Mixed Methods
8%
Parasite (Microbiology)
8%
Cost Efficiency
8%
Etiology
8%
Mental Health
8%
Case-Control Study
8%
Positioning System
7%
Disease Burden
7%
Disease Surveillance
7%
Antimicrobial Agent
7%
Hypertension
7%
Mycobacteria
7%
Diabetes Mellitus
7%
Leishmania donovani
7%
Antibiotic Resistance
7%
Medical Care
7%
Psychometry
7%
Schistosomiasis
7%
Nose Smear
6%
Dried Blood Spot
6%
Back
6%
Xenodiagnosis
6%
Tongue
6%
Thorax Radiography
6%
Child Health Service
6%
Hepatitis C Virus
6%
Maternal Mortality
6%
Atenolol
6%
Triage
6%
Therapy Delay
6%
Virus Infection
6%
Cholera
6%
Podoconiosis
6%
Intervention Study
6%
Ebolavirus
6%
Reverse Transcription Polymerase Chain Reaction
6%
Blood Buffy Coat
6%
Bacterial Pneumonia
6%
Noninferiority Trial
6%
Hepatitis C
6%
Immunology and Microbiology
Visceral Leishmaniasis
71%
Prevalence
51%
Infectious Disease
48%
Infection
43%
Human immunodeficiency virus
35%
ELISA
34%
Real-Time Polymerase Chain Reaction
29%
Mycobacterium leprae
29%
Leishmania
23%
COVID-19
22%
Trypanosoma brucei gambiense
17%
Severe Acute Respiratory Syndrome Coronavirus 2
17%
Seroprevalence
16%
Sputum
16%
Leishmania donovani
16%
Helminthiasis
14%
Drug Resistance
14%
Parasite
14%
Arm
13%
Coinfection
13%
Immunoglobulin M
13%
Glycolipid
13%
Onchocerciasis
13%
Hepatitis C
13%
Madagascar
13%
Cutaneous Leishmaniasis
12%
Phlebotominae
11%
High Risk Population
11%
Serology
11%
Hookworm
11%
Antigen
10%
Trypanosoma brucei
9%
Antigen-Antibody Interaction
9%
Seropositivity
8%
Recombinant Antigen
8%
Laboratory Test
8%
Quantitative Reverse Transcription Polymerase Chain Reaction
8%
Back
8%
Intestine Parasite
8%
Lineage
8%
Immunoassay
8%
Face
7%
Bacterial Load
7%
Screening Test
6%
Tongue
6%
Lymphadenopathy
6%
Glycoprotein
6%
Antibody Response
6%
Parasitic Disease
6%
Virus Neutralization
6%
Multidrug Resistance
6%
Drug Therapy
6%
Patient Mobility
6%
Blood Buffy Coat
6%
DNA Barcoding
6%
Whole Genome Sequencing
6%
Schistosomiasis
6%
BCG Vaccine
6%
Chikungunya virus
6%
Mycobacteria
6%
Amplicon Sequencing
6%
Schistosoma Mansoni
6%
Hepatitis C Virus
6%
Single Nucleotide Polymorphism
6%
Antibiotic Resistance
6%
Adolescence
6%
Haemophilus influenzae
6%
Population Density
6%
Mycobacterium Tuberculosis
6%
Parasite Load
6%
Wuchereria bancrofti
6%
Lateral Flow Assay
6%